Skip to main content
SpringerLink
Log in

Pathophysiology of cytotoxic drug-induced emesis: far from crystal-clear

  • Reviews
  • Published:
Pharmaceutisch Weekblad Aims and scope Submit manuscript

Abstract

Both radiotherapy and chemotherapy for cancer are capable of causing severe nausea and vomiting, which formerly often interfered with the patient's compliance to treatment. The basic pathway and pharmacological mechanisms involved in this are still poorly understood. The recent discovery, however, that 5-HT3 receptor antagonists can prevent or greatly reduce chemotherapy-induced emesis led to a re-evaluation of the sequence of events occurring in the protective emetic reflex, which are reviewed in this paper. The vomiting centre co-ordinates the incoming and outgoing information, and is thought to be represented by complex interactions between different adjacent areas in the brainstem. Whether the main role in the emetic reflex arch is accomplished by either the central part (chemoreceptor trigger zone) or the peripheral part (gastro-intestinal tract) needs further confirmation. A more important role, however, of the vagal nerve and the gastro-intestinal tract is generally accepted. The neurotransmitter serotonin (5-HT) appears to play a major role in chemotherapy-induced emesis via the 5-HT receptor. These indications could form the basis for further investigations into the involvement of other neurotransmitters, and the character of their interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Davis CJ, Harding RR, Leslie RA, Andrews PLR. The organisation of vomiting as a protective reflex. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG, eds. Nausea and vomiting: mechanisms and treatment. Berlin: Springer-Verlag, 1986:65–75.

    Google Scholar 

  2. Akwari OE. The gastrointestinal tract in chemotherapy induced emesis. Drugs 1983;25(Suppl 1):18–34.

    Google Scholar 

  3. Borison HL, Borison R, McCarthy LE. Role of the area postrema in vomiting and related functions. Fed Proc 1984;43:2955–8.

    Google Scholar 

  4. Borison HL. A 1983 neuropharmacologic perspective of space sickness. Brain Behav Evol 1983;23:7–13.

    Google Scholar 

  5. Morrow GR. The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 1985;55:2766–70.

    Google Scholar 

  6. Borison HL, Wang SC. Physiology and pharmacology of vomiting. Pharmacol Rev 1953;5:193–230.

    Google Scholar 

  7. Brizzee KR, Klara PM. Structure of the mammalian AP. Fed Proc 1984;43:2944–8.

    Google Scholar 

  8. Leslie RA. Comparative aspects of the area postrema: fine structures considerations help to determine its function. Cell Mol Neurobiol 1986;6:95–120.

    Google Scholar 

  9. Andrews PLR, Hawthorn J. Neurophysiology of vomiting. Clin Gastroenterol 1988;2:141–68.

    Google Scholar 

  10. McCarthy LE, Borison HL. Cisplatin induced vomiting eliminated by ablation of the AP in cats. Cancer Treat Rep 1984;68:401–4.

    Google Scholar 

  11. Borison HL, McCarthy LE. Neuropharmacology of cancer induced emesis. Drugs 1983;25(Suppl 1):8–17.

    Google Scholar 

  12. Lindstrom PA, Brizzee KR. Relief of intractable vomiting from surgical lesions in the area postrema. J Neurosurg 1962;19:288.

    Google Scholar 

  13. Carpenter DO, Briggs DB, Strominger N. Behavioral and electrophysiological studies of peptide-induced emesis in dogs. Fed Proc 1984;43:2952–4.

    Google Scholar 

  14. Schwartz JC, Agid Y, Bouthenet NL, et al. Neurochemical investigations into the human area postrema. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG, eds. Nausea and vomiting: mechanisms and treatment. Berlin: Springer-Verlag, 1986:18–30.

    Google Scholar 

  15. Pedigo NW, Brizzee KR. Muscarinic cholinergic receptors in AP and brainstem areas regulating emesis. Brain Res Bull 1985;14:169–77.

    Google Scholar 

  16. Reynolds DJM, Leslie RA, Grahame-Smith DG, Harvey JM. Localization of 5-HT3 receptor binding sites in human dorsal vagal complex. Eur J Pharmacol 1989;174:127–30.

    Google Scholar 

  17. Higgins GA, Kilpatrick GJ, Bunce KT, Jones BJ, Tyers MB. 5HT3 receptor antagonists injected into the AP inhibit cisplatin induced emesis in the ferret. Br J Pharmacol 1989;97:247–55.

    Google Scholar 

  18. Willems JL, Lefebvre RA. Peripheral nervous pathways involved in nausea and vomiting. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG, eds. Nausea and vomiting: mechanisms and treatment. Berlin: Springer-Verlag, 1986:56–64.

    Google Scholar 

  19. Andrews PLR, Rappeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. TiPS 1988;9:334–41.

    Google Scholar 

  20. Mitchell EP, Schein PS. Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 1982;9:52–63.

    Google Scholar 

  21. Gunning SJ, Hagan RM, Tyers MB. Cisplatin induces biochemical and histological changes in the small intestine of the ferret. Br J Pharmacol 1987;90(Suppl): 135P.

    Google Scholar 

  22. Allen SG, Smith SF. Small intestinal toxicity of cisplatin-comparison of effects of platinum analogues and dexamethasone. Br J Cancer 1986;53:355–60.

    Google Scholar 

  23. Cubbeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL. Efficacy of ondansetron and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 1990;322:810–6.

    Google Scholar 

  24. Miller AD, Wilson VJ. ‘Vomiting center’ reanalysed: an electrical stimulation study. Brain Res 1983;270:154–8.

    Google Scholar 

  25. Brizzee KR, Mehler WR. The central nervous connections in the vomiting reflex. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG, eds. Nausea and vomiting: mechanisms and treatment. Berlin: Springer-Verlag, 1986:46–55.

    Google Scholar 

  26. Geldof H, Van der Schee EJ, Van Blankenstein M, Grashuis JL. Electrogastrographic study of gastric myoelectrical activity in patients with unexplained nausea and vomiting. Gut 1986;27:799–808.

    Google Scholar 

  27. Koch KL. The irritable gut (part II): the stomach. Motility 1988;6:4–6.

    Google Scholar 

  28. Stefanini E, Clement-Carmier Y. Detection of dopamine receptors in the area postrema. Eur J Pharmacol 1981:257–60.

  29. Peroutka SJ, Snijder SH. Antiemetics: neurotransmitter receptor binding predicts antiemetic actions. Lancet 1982;1:658–9.

    Google Scholar 

  30. Peroutka SJ. Chemotherapeutic agents do not interact with neurotransmitter receptors. Cancer Chemother Pharmacol 1987;19:131–2.

    Google Scholar 

  31. Hamik A, Peroutka S. Different interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine receptors. Cancer Chemother Pharmacol 1989;24:307–10.

    Google Scholar 

  32. McRitchie B, McClelland CM, Cooper SM, Turner DH, Sanger GJ. Dopamine antagonists as anti-emetics and as stimulants of gastric motility. In: Bennett A, Velo G, eds. Mechanisms of GI motility and secretion. New York: Plenum Press, 1984:287–301.

    Google Scholar 

  33. Harris AL. Cytotoxic therapy-induced vomiting is mediated via enkephalin pathways. Lancet 1982;1:714–6.

    Google Scholar 

  34. Edwards CM. Chemotherapy induced emesis — mechanisms and treatment: a review. J R Soc Med 1988;81:658–62.

    Google Scholar 

  35. Maxwell A, Gaffin SL, Wells MT. Radiotherapy, endotoxins and nausea. Lancet 1986;2:1148–9.

    Google Scholar 

  36. Miner WD, Sanger GJ, Turner DH. Evidence that 5-hydroxy-tryptamine receptors mediate cytotoxic drug- and radiation-evoked emesis. Br J Cancer 1987;56:159–62.

    Google Scholar 

  37. Humphrey PPA, Richardson BP. Classification of 5HT receptors and binding sites: an overview. In: Mylecharane EJ, Angus JA, eds. Serotonin: actions, receptors, pathophysiology. London: MacMillan Press, 1989:204–21.

    Google Scholar 

  38. Engel G, Buchheit KH, Richardson BP. 5HT3 receptors in the gastrointestinal tract. In: Mylecharane EJ, Angus JA, eds. Serotonin: actions, receptors, pathophysiology. London: MacMillan Press, 1989:241–8.

    Google Scholar 

  39. Tyers MB, Costall B, Naylor RT. 5HT3 receptors in the CNS. In: Mylecharane EJ, Angus JA, eds. Serotonin: actions, receptors, pathophysiology. London: MacMillan Press, 1989:95–100.

    Google Scholar 

  40. Costall B, Domeney AM, Naylor RJ, Tattersall FD. 5-Hydroxytryptamine-M receptor antagonism to prevent cisplatin-induced emesis. Neuropharmacology 1986;25:959–61.

    Google Scholar 

  41. Merrifield K, Chaffee BJ. Recent advances in the management of nausea and vomiting caused by antineoplastic agents. Clin Pharm 1989;8:187–99.

    Google Scholar 

  42. Costall B, Domeney AM, Naylor RJ, Tyers MB. Effects of a 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharm 1987;92:881–94.

    Google Scholar 

  43. Grunberg S. Oh, what a tangled web. J Clin Oncol 1989;7:691–3.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Rotterdam Cancer Institute, Dr. Daniel Den Hoed Clinic, P.O. Box 5201, 3008, AE Rotterdam, The Netherlands

    C. Seynaeve & J. Verweij

  2. Department of Medical Oncology, University Hospital Saint Radboud, P.O. Box 9101, 6500, HB Nijmegen, The Netherlands

    P. H. M. De Mulder

Authors
  1. C. Seynaeve
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. H. M. De Mulder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Verweij
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seynaeve, C., De Mulder, P.H.M. & Verweij, J. Pathophysiology of cytotoxic drug-induced emesis: far from crystal-clear. Pharmaceutisch Weekblad Scientific Edition 13, 1–6 (1991). https://doi.org/10.1007/BF01963876

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01963876

Keywords

Search

Navigation